专利号:US-12351573-B2 优先权日:2019-05-09 标 题:Compounds for use in synthesis of peptidomimetics 发明人:AL-ABED YOUSEF; CHENG KAI FAN 权利人:FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH 摘要:Synthesis of O-benzotriazole and O-imidazole synthons are described. Uses of synthons in synthesis of azapeptides and other peptidomimetics, azapeptides and other peptidomimetics synthesized from the synthons and uses of azapeptides and other peptidomimetics are also described.
专利号:US-2023159450-A1 优先权日:2020-05-08 标 题 :Dimers for use in synthesis of peptidomimetics 发明人:AL-ABED YOUSEF; ALTITI AHMAD 权利人:FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH 摘要:Dimers for use in synthesis of peptidomimetics are described. Uses of dimers as synthons in synthesis of azapeptides and other peptidomimetics, azapeptides and other peptidomimetics synthesized from the dimers and uses of azapeptides and other peptidomimetics are also described.
专利号:US-2020354404-A1 优先权日:2019-05-09 标 题 :Peptidomimetic agents, synthesis and uses thereof 发明人:AL-ABED YOUSEF 权利人:FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH 摘要:Compounds for use in synthesis of peptidomimetic agents; synthesis of peptidomimetic agents; peptidomimetic diagnostic and therapeutic agents; and uses of the compounds and peptidomimetic agents in drug discovery, diagnosis, prevention and treatment of diseases are described.
专利号:US-2022401561-A1 优先权日:2019-09-30 标题 :Protein-macromolecule conjugates and methods of use thereof 发明人:SONG YUNTAO; LI HUI; ZHOU HAIPING; LIAO CHUAN 权利人:BEIJING XUANYI PHARMASCIENCES CO LTD 摘要:The present disclosure provides protein-macromolecule conjugates, releasable linkers, and macromolecules, as defined herein. The disclosed conjugates provide unique properties that ae based at least upon the properties of linker and number of linker-Macromolecule moieties. Also provided herein are a method of synthesis and use of conjugates in treating diseases and disorders.
专利号:US-11440881-B2 优先权日:2019-05-09 标题 :Thiosemicarbazates and uses thereof 发明人:AL-ABED YOUSEF; ALTITI AHMAD 权利人:FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH 摘要:Thioesters, thiocarbamates, thiocarbazates, semithiocarbazates, peptides, aza-amino acid conjugates, and azapeptides; and a chemoselective and site-specific functionalization protocol of protected thiocarbazates and semithiocarbazates are described. The protocol features the use of Mitsunobu reaction to alkylate specifically the nitrogen atom close to the acylthiol moiety with alcohols to produce protected mono-substituted thiocarbazates that can be stored for months, activated under mild conditions at low temperature using halonium reagents and integrated orthogonally to make substituted semicarbazides that can be used, e.g., as synthons in synthesis of aza-amino acid conjugates, azapeptides and other peptidomimetics. Methods for preparing and using ureases, carbazides, semicarbazides, beta-peptides, azapeptides, and other peptidomimetics and azapeptide conjugates, and uses of ureases, carbazides, semicarbazides, beta-peptides, azapeptides in drug discovery, diagnosis, inhibition, prevention and treatment of diseases are also described.
专利号:US-2022372022-A1 优先权日:2019-05-09 标 题:Compounds for use in synthesis of peptidomimetics
1: Onuki T, Hiroaki T, Sawano K, Shibata N, Nyuzuki H, Ogawa Y, Okada M, Sone H, Nagasaki K. Robust growth hormone responses to GH-releasing peptide 2 in adolescents. J Pediatr Endocrinol Metab. 2024 Jul 4;37(8):730-733. doi: 10.1515/jpem-2024-0115. 12(9):1269. doi: 10.3390/biology12091269. 3: Teramoto S, Tahara S, Hattori Y, Kondo A, Morita A. Assessment of anterior pituitary reserve capacity based on growth hormone response to growth hormone- releasing peptide-2 test in the elderly. Growth Horm IGF Res. 2023 Aug;71:101545. doi: 10.1016/j.ghir.2023.101545. Epub 2023 Jun 2. 6(8):bvac088. doi: 10.1210/jendso/bvac088. 5: Celichowska M, Miedziaszczyk M, Lacka K. Pharmacotherapy in Cachexia: A Review of Endocrine Abnormalities and Steroid Pharmacotherapy. J Pain Palliat Care Pharmacother. 2022 Jun;36(2):117-131. doi: 10.1080/15360288.2022.2063469. 14(10):e244861. doi: 10.1136/bcr-2021-244861.
合成参考文献
参考文献:10.1507/endocrj.43.291 摘要:Roh SG, Matsunaga N, Hidaka S, Hidari H. Characteristics of growth hormone secretion responsiveness to growth hormone-releasing peptide-2 (GHRP-2 or KP102) in calves. Endocr J. 1996 Jun;43(3):291–8. doi: 10.1507/endocrj.43.291. 摘要:Bowers CY, Granda-Ayala R. GHRP-2, GHRH and SRIF interrelationships during chronic administration of GHRP-2 to humans. J Pediatr Endocrinol Metab. 1996 Jun;9 Suppl 3():261–70. 参考文献:10.1210/en.143.5.1964|10.1210/endo.143.5.8893 摘要:Roh SG, Chen C, Choi KC, Shrestha Y, Sasaki S. Is GHRH receptor essential to GHRP-2-induced GH secretion in primary cultured rat pituitary cells Endocrinology. 2002 May;143(5):1964–7. doi: 10.1210/endo.143.5.8893. 参考文献:10.1007/s00210-006-0079-9 摘要:Furuta S, Hori T, Ohyama T. KP-102 (growth hormone-releasing peptide-2) attenuates ischemia/reperfusion injury in isolated rat hearts. Naunyn Schmiedebergs Arch Pharmacol. 2006 Aug;373(5):360–6. doi: 10.1007/s00210-006-0079-9. 参考文献:10.1210/jc.2011-0298 摘要:Veldhuis JD, Erickson D, Wigham J, Weist S, Miles JM, Bowers CY. Gender, Sex-Steroid, and Secretagogue-Selective Recovery from Growth Hormone-Induced Feedback in Older Women and Men. The Journal of Clinical Endocrinology & Metabolism. 2011 Aug;96(8):2540–7. doi: 10.1210/jc.2011-0298.